BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Cour Pharmaceuticals

Cour Pharmaceuticals logo

Founded
2012
Geography
United States of America based
Funding
$0.517 M

The Cour particle platforms provide a novel and highly specific immune targeting capability which may be safely applied to severe inflammatory modulation, and immune (antigen) tolerization.

Technologies

Nanomedicine   Pharmaceutical and Drug Discovery  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet